vs

Side-by-side financial comparison of LUXFER HOLDINGS PLC (LXFR) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

LUXFER HOLDINGS PLC is the larger business by last-quarter revenue ($90.7M vs $76.4M, roughly 1.2× PROCEPT BioRobotics Corp). LUXFER HOLDINGS PLC runs the higher net margin — -3.4% vs -39.1%, a 35.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -12.3%). LUXFER HOLDINGS PLC produced more free cash flow last quarter ($12.4M vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 0.7%).

Luxfer Holdings PLC is a global industrial manufacturer specializing in high-performance engineering materials and components. Its core products include lightweight aluminum and composite gas containment systems, advanced alloys, and specialty materials, serving key sectors such as aerospace, healthcare, automotive, industrial manufacturing, and alternative energy worldwide.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LXFR vs PRCT — Head-to-Head

Bigger by revenue
LXFR
LXFR
1.2× larger
LXFR
$90.7M
$76.4M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+24.2% gap
PRCT
11.9%
-12.3%
LXFR
Higher net margin
LXFR
LXFR
35.7% more per $
LXFR
-3.4%
-39.1%
PRCT
More free cash flow
LXFR
LXFR
$24.6M more FCF
LXFR
$12.4M
$-12.2M
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
0.7%
LXFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LXFR
LXFR
PRCT
PRCT
Revenue
$90.7M
$76.4M
Net Profit
$-3.1M
$-29.8M
Gross Margin
24.4%
60.6%
Operating Margin
3.6%
-40.6%
Net Margin
-3.4%
-39.1%
Revenue YoY
-12.3%
11.9%
Net Profit YoY
-188.6%
-58.3%
EPS (diluted)
$-0.12
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LXFR
LXFR
PRCT
PRCT
Q4 25
$90.7M
$76.4M
Q3 25
$92.9M
$83.3M
Q2 25
$104.0M
$79.2M
Q1 25
$97.0M
$69.2M
Q4 24
$103.4M
$68.2M
Q3 24
$99.4M
$58.4M
Q2 24
$99.7M
$53.4M
Q1 24
$89.4M
$44.5M
Net Profit
LXFR
LXFR
PRCT
PRCT
Q4 25
$-3.1M
$-29.8M
Q3 25
$2.7M
$-21.4M
Q2 25
$2.6M
$-19.6M
Q1 25
$5.5M
$-24.7M
Q4 24
$3.5M
$-18.9M
Q3 24
$12.7M
$-21.0M
Q2 24
$-500.0K
$-25.6M
Q1 24
$2.7M
$-26.0M
Gross Margin
LXFR
LXFR
PRCT
PRCT
Q4 25
24.4%
60.6%
Q3 25
23.4%
64.8%
Q2 25
23.1%
65.4%
Q1 25
22.1%
63.9%
Q4 24
22.1%
64.0%
Q3 24
22.5%
63.2%
Q2 24
22.1%
59.0%
Q1 24
20.6%
56.2%
Operating Margin
LXFR
LXFR
PRCT
PRCT
Q4 25
3.6%
-40.6%
Q3 25
5.8%
-27.8%
Q2 25
7.4%
-28.0%
Q1 25
7.8%
-39.7%
Q4 24
3.9%
-28.9%
Q3 24
17.5%
-38.4%
Q2 24
3.8%
-50.3%
Q1 24
5.5%
-62.1%
Net Margin
LXFR
LXFR
PRCT
PRCT
Q4 25
-3.4%
-39.1%
Q3 25
2.9%
-25.7%
Q2 25
2.5%
-24.7%
Q1 25
5.7%
-35.8%
Q4 24
3.4%
-27.6%
Q3 24
12.8%
-35.9%
Q2 24
-0.5%
-48.0%
Q1 24
3.0%
-58.3%
EPS (diluted)
LXFR
LXFR
PRCT
PRCT
Q4 25
$-0.12
$-0.54
Q3 25
$0.10
$-0.38
Q2 25
$0.10
$-0.35
Q1 25
$0.20
$-0.45
Q4 24
$0.13
$-0.34
Q3 24
$0.47
$-0.40
Q2 24
$-0.02
$-0.50
Q1 24
$0.10
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LXFR
LXFR
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$8.3M
$286.5M
Total DebtLower is stronger
$39.4M
$51.6M
Stockholders' EquityBook value
$226.4M
$365.9M
Total Assets
$369.7M
$508.1M
Debt / EquityLower = less leverage
0.17×
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LXFR
LXFR
PRCT
PRCT
Q4 25
$8.3M
$286.5M
Q3 25
$6.0M
$294.3M
Q2 25
$4.4M
$302.7M
Q1 25
$4.1M
$316.2M
Q4 24
$4.1M
$333.7M
Q3 24
$3.5M
$196.8M
Q2 24
$4.3M
$214.1M
Q1 24
$6.8M
$225.6M
Total Debt
LXFR
LXFR
PRCT
PRCT
Q4 25
$39.4M
$51.6M
Q3 25
$43.3M
$51.6M
Q2 25
$52.6M
$51.5M
Q1 25
$46.0M
$51.5M
Q4 24
$45.1M
$51.5M
Q3 24
$69.5M
$51.4M
Q2 24
$74.2M
$51.4M
Q1 24
$78.4M
$51.4M
Stockholders' Equity
LXFR
LXFR
PRCT
PRCT
Q4 25
$226.4M
$365.9M
Q3 25
$231.6M
$380.3M
Q2 25
$237.7M
$385.8M
Q1 25
$226.7M
$389.2M
Q4 24
$219.5M
$402.2M
Q3 24
$225.1M
$241.2M
Q2 24
$206.3M
$251.8M
Q1 24
$210.3M
$264.0M
Total Assets
LXFR
LXFR
PRCT
PRCT
Q4 25
$369.7M
$508.1M
Q3 25
$377.4M
$511.5M
Q2 25
$399.2M
$513.1M
Q1 25
$385.2M
$519.4M
Q4 24
$382.4M
$534.0M
Q3 24
$404.8M
$374.1M
Q2 24
$379.8M
$374.4M
Q1 24
$386.0M
$382.9M
Debt / Equity
LXFR
LXFR
PRCT
PRCT
Q4 25
0.17×
0.14×
Q3 25
0.19×
0.14×
Q2 25
0.22×
0.13×
Q1 25
0.20×
0.13×
Q4 24
0.21×
0.13×
Q3 24
0.31×
0.21×
Q2 24
0.36×
0.20×
Q1 24
0.37×
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LXFR
LXFR
PRCT
PRCT
Operating Cash FlowLast quarter
$15.6M
$-10.3M
Free Cash FlowOCF − Capex
$12.4M
$-12.2M
FCF MarginFCF / Revenue
13.7%
-15.9%
Capex IntensityCapex / Revenue
3.5%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.2M
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LXFR
LXFR
PRCT
PRCT
Q4 25
$15.6M
$-10.3M
Q3 25
$11.8M
$-6.6M
Q2 25
$1.2M
$-15.0M
Q1 25
$5.4M
$-17.0M
Q4 24
$25.5M
$-32.4M
Q3 24
$13.0M
$-18.8M
Q2 24
$8.9M
$-15.7M
Q1 24
$3.7M
$-32.3M
Free Cash Flow
LXFR
LXFR
PRCT
PRCT
Q4 25
$12.4M
$-12.2M
Q3 25
$10.3M
$-9.5M
Q2 25
$-700.0K
$-17.8M
Q1 25
$4.2M
$-18.8M
Q4 24
$22.5M
$-33.6M
Q3 24
$9.8M
$-19.0M
Q2 24
$6.2M
$-16.8M
Q1 24
$2.3M
$-34.2M
FCF Margin
LXFR
LXFR
PRCT
PRCT
Q4 25
13.7%
-15.9%
Q3 25
11.1%
-11.4%
Q2 25
-0.7%
-22.5%
Q1 25
4.3%
-27.2%
Q4 24
21.8%
-49.2%
Q3 24
9.9%
-32.6%
Q2 24
6.2%
-31.4%
Q1 24
2.6%
-76.9%
Capex Intensity
LXFR
LXFR
PRCT
PRCT
Q4 25
3.5%
2.4%
Q3 25
1.6%
3.4%
Q2 25
1.8%
3.5%
Q1 25
1.2%
2.7%
Q4 24
2.9%
1.7%
Q3 24
3.2%
0.4%
Q2 24
2.7%
2.0%
Q1 24
1.6%
4.4%
Cash Conversion
LXFR
LXFR
PRCT
PRCT
Q4 25
Q3 25
4.37×
Q2 25
0.46×
Q1 25
0.98×
Q4 24
7.29×
Q3 24
1.02×
Q2 24
Q1 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LXFR
LXFR

Gas Cylinders Segment$43.8M48%
Defense First Response And Healthcare$18.6M21%
Rest Of Europe$9.0M10%
DE$7.0M8%
Asia Pacific$5.8M6%
CA$4.0M4%
Other$2.5M3%

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons